Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 7, p. 585, doi. 10.1038/cgt.2009.4
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2009 AND VI 16 AND IP 7
Results: 7
1
2
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 7, p. 551, doi. 10.1038/cgt.2009.10
- By:
- Publication type:
- Article
3
M-PEIs nanogels: potential nonviral vector for systemic plasmid delivery to tumor cells.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 7, p. 561, doi. 10.1038/cgt.2009.11
- By:
- Publication type:
- Article
4
NT-polyplex: a new tool for therapeutic gene delivery to neuroblastoma tumors.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 7, p. 573, doi. 10.1038/cgt.2009.1
- By:
- Publication type:
- Article
5
Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 7, p. 541, doi. 10.1038/cgt.2009.25
- By:
- Publication type:
- Article
6
Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon α: possible use as a surrogate marker.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 7, p. 567, doi. 10.1038/cgt.2009.2
- By:
- Publication type:
- Article
7
Immune response to vaccination with DNA-hsp65 in a phase I clinical trial with head and neck cancer patients.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 7, p. 598, doi. 10.1038/cgt.2009.9
- By:
- Publication type:
- Article